Evidence map›Paper›PMID 32440779›Full record

ArticlePsychopharmacology2020

Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats.

Haritz Jiménez-Urbieta, Belén Gago, Ana Quiroga-Varela, Tatiana Rodríguez-Chinchilla, Leyre Merino-Galán, Manuel Delgado-Alvarado, Irene Navalpotro-Gómez, Arantzazu Belloso-Iguerategui, Concepció Marin, María C Rodríguez-Oroz

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Haritz Jiménez-UrbietaInstituto de Investigación Sanitaria Biodonostia, San Sebastián, Spain.
Belén GagoInstituto de Investigación Biomédica de Málaga, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
Ana Quiroga-VarelaCentro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain.
Tatiana Rodríguez-ChinchillaCentro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain.
Leyre Merino-GalánCentro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain.
Manuel Delgado-AlvaradoNeurology Department, Sierrallana Hospital, Torrelavega, Spain.
Irene Navalpotro-GómezInstitut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.
Arantzazu Belloso-IguerateguiCentro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain.
Concepció MarinIRCE, Institut d' investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
María C Rodríguez-OrozCentro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain. mcroroz@unav.es.
Universidad de Navarra · ESBiogipuzkoa Health Research Institute · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital del Mar Research Institute · ESInstituto de Investigación Marqués de Valdecilla · ESUniversidad de Málaga · ESUniversity of the Basque Country · ES

Funding

Diputación Foral de Guipúzcoa DFG11/019Instituto de Salud Carlos III PI11/02109
6 · The paper itself

Abstract

rationaleImpulse control disorders (ICD) and other impulsive-compulsive behaviours are frequently found in Parkinson's disease (PD) patients treated with dopaminergic agonists. To date, there are no available animal models to investigate their pathophysiology and determine whether they can be elicited by varying doses of dopaminergic drugs. In addition, there is some controversy regarding the predispositional pattern of striatal dopaminergic depletion.

objectivesTo study the effect of two doses of pramipexole (PPX) on motor impulsivity, delay intolerance and compulsive-like behaviour.

methodsMale rats with mild dopaminergic denervation in the dorsolateral striatum (bilateral injections of 6-hydroxidopamine (6-OHDA)) treated with two doses of PPX (0.25 mg/kg and 3 mg/kg) and tested in the variable delay-to-signal paradigm.

resultsPartial (50%) dopaminergic depletion did not induce significant changes in motor impulsivity or delay intolerance. However, 0.25 mg/kg of PPX increased motor impulsivity, while 3 mg/kg of PPX increased both motor impulsivity and delay intolerance. These effects were independent of the drug's antiparkinsonian effects. Importantly, impulsivity scores before and after dopaminergic lesion were positively associated with the impulsivity observed after administering 3 mg/kg of PPX. No compulsive-like behaviour was induced by PPX administration.

conclusionsWe described a rat model, with a moderate dorsolateral dopaminergic lesion resembling that suffered by patients with early PD, that develops different types of impulsivity in a dose-dependent manner dissociated from motor benefits when treated with PPX. This model recapitulates key features of abnormal impulsivity in PD and may be useful for deepening our understanding of the pathophysiology of ICD.

Indexed as

AnimalsCorpus StriatumDisruptive, Impulse Control, and Conduct DisordersDopamineDopamine AgonistsDose-Response Relationship, DrugImpulsive BehaviorMaleMotor ActivityOxidopamineParkinsonian DisordersPramipexoleRatsRats, Sprague-DawleyDopamineDopamine AgonistsOxidopaminePramipexole6-OHDADelay intoleranceImpulse control disordersMotor impulsivityParkinson’s diseasePramipexoleRatStriatumVariable delay-to-signal task

Identifiers

PMID32440779
OpenAlexW3028115991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.